Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 148 of 173

  1. US 6899880

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia

    Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  2. US 6899892

    Methods to reduce body fat

    Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  3. US 6897016

    Alteration of sequence of a target molecule

    Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  4. US 6897196

    pH sensitive lipids based on ortho ester linkers, composition and method

    Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  5. US 6894154

    hKIS compositions and methods of use

    Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  6. US 6893643

    Recombinant yellow fever virus and methods of use thereof

    Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  7. US 6893821

    Agents that modulate DNA-PK activity and methods of use thereof

    Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  8. US 6894027

    Stimulation of bone growth with thrombin peptide derivatives

    Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  9. US 6890949

    Amino ceramide-like compounds and therapeutic methods of use

    Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  10. US 6890537

    Antimicrobial theta defensins and methods of using same

    Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  11. US 6890552

    Manufacturing therapeutic enclosures

    Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  12. US 6890738

    Prolactin antagonists and uses thereof

    Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  13. US 6890721

    Interleukin-1Ξ² converting enzyme like apoptotic protease-6

    Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  14. US 6890311

    Methods for performing medical procedures within a breast duct

    Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  15. US 6887902

    Anti-inflammatory method using gamma-aminobutyric acid (GABA) analogs

    Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  16. US 6887483

    Non-toxic mutants of pathogenic gram-negative bacteria

    Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  17. US 6887468

    Antibody kits for selectively inhibiting VEGF

    Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  18. US 6887489

    Propionibacterium P-63 for use in direct fed microbials for animal feeds

    Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  19. US 6884596

    Screening and therapeutic methods for promoting wakefulness and sleep

    Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  20. US 6884577

    Methods for screening compounds for estrogenic activity

    Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  21. US 6884585

    Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor

    Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  22. US 6884431

    Method for treating proliferative diseases with p27 and fusions thereof

    Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  23. US 6881857

    Tricyclic diterpene derivatives

    Expires Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  24. US 6881822

    PSCA: prostate stem cell antigen and uses thereof

    Expires Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  25. US 6878816

    Vmp-like sequences of pathogenic Borrelia

    Expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  26. US 6875419

    Paramagnetic metal ion-based macrocyclic magnetization transfer contrast agents and method of use

    Expires Mon Mar 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  27. US 6875849

    Methods of recovering chaperone proteins and complexes thereof

    Expires Mon Mar 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  28. US 6872385

    Adjuvant preparation for the induction of specific immunity

    Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  29. US 6872387

    Three-dimensional hydrogel/cell system

    Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  30. US 6872750

    Modulating angiogenesis

    Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  31. US 6870042

    Mutants of streptococcal toxin A and methods of use

    Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  32. US 6869568

    Functional assay of high-density lipoprotein

    Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  33. US 6869777

    Mini-dystrophin nucleic acid sequences

    Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  34. US 6866845

    Compositions and methods for the treatment of sepsis

    Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  35. US 6867022

    Replication deficient adenovirus vectors and methods of making and using them

    Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  36. US 6867353

    Production method of recombinant rotavirus structural proteins and vaccine composition

    Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  37. US 6867289

    Thio-modified aptamer synthetic methods and compositions

    Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  38. US 6867190

    Methods of therapy with thrombin derived peptides

    Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  39. US 6864066

    Epithelial protein lost in neoplasm (EPLIN)

    Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  40. US 6862890

    Process for production of nanoparticles and microparticles by spray freezing into liquid

    Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  41. US 6864301

    Preparation and use of photopolymerized microparticles

    Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  42. US 6864103

    Phthalamide-lanthanide complexes for use as luminescent markers

    Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  43. US 6863895

    Mycobacterial sulfation pathway proteins and methods of use thereof

    Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  44. US 6863888

    Oncoprotein protein kinase

    Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  45. US 6861407

    Methods of therapy with thrombin derived peptides

    Expires Mon Feb 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  46. US 6861228

    Modulating Robo: ligand interactions

    Expires Mon Feb 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  47. US 6858402

    System for discovering and producing polypeptides that cause TNF receptor shedding

    Expires Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  48. US 6858409

    Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors

    Expires Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory